ABC IVF
DEAD

Serial Number

79220046

Owner

Create Health Ltd

Filing Date

Aug 10, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ABC IVF Trademark

Serial Number: 79220046

ABC IVF is a trademark filed by Create Health Ltd on August 10, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Create Health Ltd

Accountancy House,

Entity Type: 16

Trademark Details

Filing Date

August 10, 2017

Registration Date

Not Registered

Goods & Services

Education and training services; training and educational services relating to medical and healthcare services; training and educational services relating to fertility, infertility and pregnancy; training and educational services relating to gynaecology

Downloadable electronic publications, magazines, brochures, leaflets; computer software; computer application software; downloadable computer software accessible via the internet and wireless devices enabling the recording and examination of information relating to fertility and infertility; scientific apparatus and instruments; teaching apparatus and instruments

In vitro preparations for medical use; fertility enhancement preparations; dietary and nutritional supplements; fertility enhancement preparations; injectable preparations for the treatment of sexual impotency; preparations for the treatment of fertility diseases; in vitro preparations for predicting ovulation; in vitro diagnostic preparations for medical purposes; preparations for the diagnosis of pregnancy; chemical preparations for the in-vivo diagnosis of pregnancy; medicated preparations for the diagnosis of pregnancy; pregnancy testing preparations; reagents for use in diagnostic pregnancy tests; ovulation test kits; preparations for detecting mutation in prion genes for medical purposes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for hydrating the skin during pregnancy; preparations for the diagnosis of ovulation; in vitro gender prediction test kits; in vitro preparations for predicting ovulation

Printed matter, publications; planners; charts for the purposes of recording and examining information relating to personal fertility and infertility; printed instructional and educational material relating to medical services and healthcare services; printed instructional and educational material relating to fertility, infertility and pregnancy; printed instructional and educational material relating to gynaecology

Management of health care clinics; advertising; business administration

Diagnostic reagents for in vitro use; biochemical for in vitro use/diagnostics; biochemicals namely, polypeptides for in vitro research use; biochemicals namely, precursors for in vitro genetic engineering use; diagnostic reagents for in-vitro use other than medical; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemicals for use in the purification of proteins for in vitro use; reagents for in-vitro laboratory use other than for medical or veterinary purposes

In vitro fertilisation services; in vitro fertilisation segmentation services, medical clinic services; medical services in the field of in vitro fertilization; medical consultations; medical services and healthcare services; medical and healthcare services relating to fertility, infertility and pregnancy; medical and healthcare services for women and couples; gynaecological services for women; human healthcare services; medical care and medical analysis services relating to the field of infertility treatment and fertility disorders; human fertility treatment services; herbalism services; alternative medicine services; sperm-bank services; medical testing in relation to anti-mullerian hormones; human sperm donation services; human embryo freezing services; medical services in relation to intra-uterine insemination; medical services relating to tubal patency testing; medical services relating to hysteroscopy; hormone treatment services

Surgical, medical apparatus and instruments; diagnostic apparatus for pregnancy testing

Clinical research, clinical trials; scientific and technological services and research in the field of infertility treatment and fertility disorders

Filing History

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 7, 2022 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Jun 26, 2022 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Jun 24, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 11, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 13, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 23, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2019 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jul 10, 2019 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 10, 2019 FICR
NEW REPRESENTATIVE AT IB RECEIVED
May 24, 2019 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 19, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 3, 2019 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 10, 2018 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 10, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 10, 2018 ABN2
ATTORNEY REVIEW COMPLETED
Jun 5, 2018 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
May 29, 2018 LIME
LIMITATION OF GOODS RECEIVED FROM IB
May 18, 2018 LIMG
REFUSAL PROCESSED BY IB
Dec 23, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 5, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 5, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 21, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 20, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 14, 2017 MAFR
ASSIGNED TO EXAMINER
Nov 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 7, 2017 REPR